The highlight of the report is the margin. The company widened margins significantly, reporting a 79.5% gross margin, 85.1% adjusted, and a 14% adjusted operating margin, up nearly 1000 bps YOY. The net result is adjusted EPS of $0.16, up a dime compared to last year despite a higher share count. Adjusted EPS beat the Marketbeat.com consensus by $0.02, suggesting the guidance may be cautious.
The company's guidance plays into the decline in stock price. The guidance was raised at the top and bottom line but forecasts additional slowing and aligns with the consensus. The opportunity for investors is that this company shows momentum and will likely outperform and raise guidance as the year progresses. In this light, the 12% stock price decline is a knee-jerk reaction to news that has reset the market and positioned it for a solid rebound.
The first two analyst revisions to pop up following the release include price target reductions, but that is the worst that can be said. The reductions come from Morgan Stanley and Needham to $47 and $45, both above the consensus. The consensus has been trending higher; that trend may be over, but it is up 60% YOY, showing a high level of conviction among analysts and 20% above the current action. Analysts' consensus aligns with the recent highs and may cap gains until later in the year.
The technical action is mixed. The post-release plunge is concerning but has not crossed critical support targets and aligns with a larger reversal pattern. JFrog stock hit bottom in 2022, confirmed it in 2023, and began to rally higher later that year. Now, it is pulling back from a higher high to confirm support at a higher low possibly. The support target near $35 is a significant pivot point if confirmed. In that scenario, the market should begin to rebound soon and may retest the recent highs by mid-summer. If not, JFrog could fall to a new low and continue lower to the next target for support near $30.
Before you consider JFrog, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and JFrog wasn't on the list.
While JFrog currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free ReportCompany | MarketRank™ | Current Price | Price Change | Dividend Yield | P/E Ratio | Consensus Rating | Consensus Price Target |
---|---|---|---|---|---|---|---|
GitLab (GTLB) | 2.6177 of 5 stars | $66.62 | +2.8% | N/A | -28.47 | Moderate Buy | $66.67 |
JFrog (FROG) | 3.699 of 5 stars | $32.15 | +0.7% | N/A | -60.66 | Moderate Buy | $37.72 |
Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools.
Start Your 30-Day Trial